Medical College Of Wisconsin
Clinical trials sponsored by Medical College Of Wisconsin, explained in plain language.
-
Heart scan tracer may reveal Chemo's effect on amyloid buildup
Disease control TerminatedThis pilot study tests whether a special PET scan tracer called 18F florbetapir can detect changes in amyloid protein deposits in the heart of people with AL cardiac amyloidosis who are receiving chemotherapy. Four participants will have a PET/CT scan before starting chemotherapy…
Phase: PHASE4 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Experimental chemo cocktail targets resistant leukemia
Disease control TerminatedThis study tested a combination of chemotherapy drugs (cladribine, cytarabine, mitoxantrone, and G-CSF) in 53 adults with acute myeloid leukemia (AML) or high-risk myelodysplastic syndrome (MDS) that had come back or not responded to prior treatment. The goal was to see how many …
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Engineered immune cells take aim at Tough-to-Treat leukemia
Disease control TerminatedThis early-phase study tested a personalized cell therapy (CAR-T) for people with B-cell acute lymphoblastic leukemia that returned or didn't respond to standard treatments. The therapy used the patient's own immune cells, modified to target two markers (CD19 and CD20) on leukemi…
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC
-
Experimental drug pacritinib tested for returning prostate cancer – but trial stopped early
Disease control TerminatedThis phase 2 trial tested the drug pacritinib in 6 men whose prostate cancer had come back after surgery or radiation, shown by rising PSA levels. The goal was to see if the drug could delay further cancer growth. However, the study was terminated early, so we have limited inform…
Phase: PHASE2 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Experimental drug combo for pancreatic cancer shows early promise, but trial halted
Disease control TerminatedThis early-phase trial tested a drug called CPI-613 (devimistat) combined with chemotherapy and radiation for people with pancreatic cancer that cannot be surgically removed. The goal was to find the safest dose. Only 8 people took part before the study was stopped. While the app…
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Clinic ultrasound may catch fatty liver on the spot
Diagnosis TerminatedThis study is testing whether a simple ultrasound done right in the doctor's office can help diagnose fatty liver disease early. Researchers will compare the bedside scan results with standard radiology imaging in 500 patients. If it works, it could make diagnosis faster and more…
Sponsor: Medical College of Wisconsin • Aim: Diagnosis
Last updated Jul 15, 2026 00:00 UTC
-
Can a simple patch replace opioids for broken ribs in seniors?
Symptom relief TerminatedThis trial investigates whether lidocaine patches can help older adults (65+) with rib fractures use fewer opioids while maintaining pain control. Participants receive either a lidocaine patch, a placebo patch, or standard care. The study measures opioid use and pain scores durin…
Phase: PHASE4 • Sponsor: Medical College of Wisconsin • Aim: Symptom relief
Last updated Jul 10, 2026 00:00 UTC
-
Ear device could tame dangerous brain injury symptoms in kids
Symptom relief TerminatedThis study tested a small device placed on the ear that sends gentle electrical pulses to calm overactive nerves in children with severe brain injury. The goal was to reduce sudden episodes of fast heart rate, high blood pressure, and other symptoms. The trial was very small and …
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Symptom relief
Last updated Jun 27, 2026 12:28 UTC
-
Ear zapper aims to replace opioids for vomiting syndrome
Symptom relief TerminatedThis study tested a small device that stimulates nerves in the ear to help people with cyclic vomiting syndrome feel less pain, nausea, and vomiting. The goal was to see if it could reduce the need for strong painkillers like opioids. Only 4 people took part before the study was …
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Symptom relief
Last updated Jun 27, 2026 12:03 UTC
-
Ear zap device tested for chemo nausea in kids – but study stopped early
Symptom relief TerminatedThis study tested a small device that stimulates a nerve in the ear to see if it can reduce nausea and vomiting caused by chemotherapy in children, teens, and young adults. The device, called IBStim, was compared to a sham (fake) device. The trial was terminated early and include…
Phase: NA • Sponsor: Medical College of Wisconsin • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Can early feeding behaviors predict later oral feeding trouble in tube-fed infants?
Knowledge-focused TerminatedThis study watches hospitalized infants who receive long-term tube feedings to see how their behaviors around feeding change over time. Researchers compare these infants to those fed orally, looking for early clues that might predict oral feeding difficulty later in life. The goa…
Sponsor: Medical College of Wisconsin • Aim: Knowledge-focused
Last updated Aug 01, 2026 00:00 UTC